BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferramosca A, Di Giacomo M, Zara V. Antioxidant dietary approach in treatment of fatty liver: New insights and updates. World J Gastroenterol 2017; 23(23): 4146-4157 [PMID: 28694655 DOI: 10.3748/wjg.v23.i23.4146] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 48] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Murai T, Kawasumi K, Tominaga K, Okada Y, Kobayashi M, Arai T. Effects of astaxanthin supplementation in healthy and obese dogs. Vet Med (Auckl) 2019;10:29-35. [PMID: 30859086 DOI: 10.2147/VMRR.S186202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shi K, Li R, Xu Z, Zhang Q. Identification of Crucial Genetic Factors, Such as PPARγ, that Regulate the Pathogenesis of Fatty Liver Disease in Dairy Cows Is Imperative for the Sustainable Development of Dairy Industry. Animals (Basel) 2020;10:E639. [PMID: 32272794 DOI: 10.3390/ani10040639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Mafra D, Gidlund E, Borges NA, Magliano DC, Lindholm B, Stenvinkel P, von Walden F. Bioactive food and exercise in chronic kidney disease: Targeting the mitochondria. Eur J Clin Invest 2018;48:e13020. [DOI: 10.1111/eci.13020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
4 Ferro Y, Montalcini T, Mazza E, Foti D, Angotti E, Gliozzi M, Nucera S, Paone S, Bombardelli E, Aversa I, Musolino V, Mollace V, Pujia A. Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years. Front Endocrinol (Lausanne) 2020;11:494. [PMID: 32849284 DOI: 10.3389/fendo.2020.00494] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
5 Izzo C, Annunziata M, Melara G, Sciorio R, Dallio M, Masarone M, Federico A, Persico M. The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. Nutrients 2021;13:933. [PMID: 33805795 DOI: 10.3390/nu13030933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bingül İ, Aydın AF, Küçükgergin C, Doğan-Ekici I, Doğru-Abbasoğlu S, Uysal M. The effect of 1,25-dihydroxyvitamin D3 on liver damage, oxidative stress, and advanced glycation end products in experimental nonalcoholic- and alcoholic- fatty liver disease. Turk J Med Sci 2021;51:1500-11. [PMID: 33421970 DOI: 10.3906/sag-2007-289] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang R, Chu K, Zhao N, Wu J, Ma L, Zhu C, Chen X, Wei G, Liao M. Corilagin Alleviates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced C57BL/6 Mice by Ameliorating Oxidative Stress and Restoring Autophagic Flux. Front Pharmacol 2019;10:1693. [PMID: 32116684 DOI: 10.3389/fphar.2019.01693] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
8 Dolezelova E, Prasnicka A, Cermanova J, Carazo A, Hyrsova L, Hroch M, Mokry J, Adamcova M, Mrkvicova A, Pavek P, Micuda S. Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. World J Gastroenterol 2017;23:7678-92. [PMID: 29209109 DOI: 10.3748/wjg.v23.i43.7678] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Recena Aydos L, Aparecida do Amaral L, Serafim de Souza R, Jacobowski AC, Freitas Dos Santos E, Rodrigues Macedo ML. Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models. Nutrients 2019;11:E3067. [PMID: 31888190 DOI: 10.3390/nu11123067] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
10 Fadda LM, Ali HM, Mohamed AM, Hagar H. Prophylactic administration of carnosine and melatonin abates the incidence of apoptosis, inflammation, and DNA damage induced by titanium dioxide nanoparticles in rat livers. Environ Sci Pollut Res Int 2020;27:19142-50. [PMID: 31055753 DOI: 10.1007/s11356-019-05059-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Chen L, Liu J, Mei G, Chen H, Peng S, Zhao Y, Yao P, Tang Y. Quercetin and non-alcoholic fatty liver disease: A review based on experimental data and bioinformatic analysis. Food Chem Toxicol 2021;154:112314. [PMID: 34087406 DOI: 10.1016/j.fct.2021.112314] [Reference Citation Analysis]
12 Kim SH, Kim H. Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review. Nutrients 2018;10:E1137. [PMID: 30134611 DOI: 10.3390/nu10091137] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 17.0] [Reference Citation Analysis]
13 Lee MR, Kim JE, Park JW, Kang MJ, Choi HJ, Bae SJ, Choi YW, Kim KM, Hong JT, Hwang DY. Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway. BMC Complement Med Ther 2020;20:283. [PMID: 32948162 DOI: 10.1186/s12906-020-03076-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Fernández-Palanca P, Fondevila F, Méndez-Blanco C, Tuñón MJ, González-Gallego J, Mauriz JL. Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review. Nutrients 2019;11:E2875. [PMID: 31775362 DOI: 10.3390/nu11122875] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
15 Di Ciaula A, Passarella S, Shanmugam H, Noviello M, Bonfrate L, Wang DQ, Portincasa P. Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies? Int J Mol Sci 2021;22:5375. [PMID: 34065331 DOI: 10.3390/ijms22105375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Di Ciaula A, Calamita G, Shanmugam H, Khalil M, Bonfrate L, Wang DQ, Baffy G, Portincasa P. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. Int J Mol Sci 2021;22:7702. [PMID: 34299321 DOI: 10.3390/ijms22147702] [Reference Citation Analysis]
17 Kravchenko LV, Aksenov IV, Nikitin NS, Guseva GV, Avrenyeva LI, Trusov NV, Balakina AS, Tutelyan VA. Lipoic Acid Exacerbates Oxidative Stress and Lipid Accumulation in the Liver of Wistar Rats Fed a Hypercaloric Choline-Deficient Diet. Nutrients 2021;13:1999. [PMID: 34200615 DOI: 10.3390/nu13061999] [Reference Citation Analysis]
18 Deenin W, Malakul W, Boonsong T, Phoungpetchara I, Tunsophon S. Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression. World J Hepatol 2021;13:315-27. [PMID: 33815675 DOI: 10.4254/wjh.v13.i3.315] [Reference Citation Analysis]
19 Uyar A, Yaman T. Evaluation with endothelial nitric oxide synthase (eNOS) immunoreactivity of the protective role of astaxanthin on hepatorenal injury of remote organs caused by ischaemia reperfusion of the lower extremities. Prz Gastroenterol 2020;15:161-72. [PMID: 32550950 DOI: 10.5114/pg.2019.88620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zhu Y, Liu R, Shen Z, Cai G. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathway. Life Sciences 2020;256:117990. [DOI: 10.1016/j.lfs.2020.117990] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
21 Saleh Al-Maamari JN, Rahmadi M, Panggono SM, Prameswari DA, Pratiwi ED, Ardianto C, Balan SS, Suprapti B. The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice. J Basic Clin Physiol Pharmacol 2021;32:637-44. [PMID: 34214346 DOI: 10.1515/jbcpp-2020-0423] [Reference Citation Analysis]
22 Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Joukar F. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Integr Med Res 2019;8:57-61. [PMID: 30949432 DOI: 10.1016/j.imr.2018.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
23 Lian C, Zhai Z, Li Z, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 2020;330:109199. [DOI: 10.1016/j.cbi.2020.109199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
24 Qin SH, Lau ATY, Liang ZL, Tan HW, Ji YC, Zhong QH, Zhao XY, Xu YM. Resveratrol Promotes Tumor Microvessel Growth via Endoglin and Extracellular Signal-Regulated Kinase Signaling Pathway and Enhances the Anticancer Efficacy of Gemcitabine against Lung Cancer. Cancers (Basel) 2020;12:E974. [PMID: 32326402 DOI: 10.3390/cancers12040974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Yan K, Wang X, Pan H, Wang L, Yang H, Liu M, Zhu H, Gong F. Safflower Yellow and Its Main Component HSYA Alleviate Diet-Induced Obesity in Mice: Possible Involvement of the Increased Antioxidant Enzymes in Liver and Adipose Tissue. Front Pharmacol 2020;11:482. [PMID: 32372961 DOI: 10.3389/fphar.2020.00482] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
26 Coelho JM, Cansanção K, Perez RM, Leite NC, Padilha P, Ramalho A, Peres W. Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study. PeerJ 2020;8:e9838. [PMID: 32995080 DOI: 10.7717/peerj.9838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Moradi R, Hajialiani M, Salmani S, Almasi M, Zangeneh A, Zangeneh MM. Effect of aqueous extract of Allium saralicum R.M. Fritsch on fatty liver induced by high-fat diet in Wistar rats. Comp Clin Pathol 2019;28:1205-11. [DOI: 10.1007/s00580-018-2834-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 8] [Article Influence: 13.3] [Reference Citation Analysis]
28 Liu S, Yuan J, Yue W, Bi Y, Shen X, Gao J, Xu X, Lu Z. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice. Biochim Biophys Acta Mol Basis Dis 2018;1864:3257-67. [PMID: 30006154 DOI: 10.1016/j.bbadis.2018.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
29 Lee E, Lim Y, Kwon SW, Kwon O. Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. The Journal of Nutritional Biochemistry 2019;68:33-41. [DOI: 10.1016/j.jnutbio.2019.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
30 Hidalgo I, Nájera N, Meaney E, Pérez-Durán J, Valdespino-Vazquez Y, Villarreal F, Ceballos G. Effects of (-)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis. J Nutr Biochem 2020;77:108296. [PMID: 32007822 DOI: 10.1016/j.jnutbio.2019.108296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Zhong QW, Wu YY, Xiong F, Liu M, Liu YP, Wang C, Chen YM. Higher flavonoid intake is associated with a lower progression risk of non-alcoholic fatty liver disease in adults: a prospective study. Br J Nutr 2021;125:460-70. [PMID: 32713378 DOI: 10.1017/S0007114520002846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Franklin R, Bispo RFM, Sousa-Rodrigues CF, Pires LAS, Fonseca A Jr, Babinski MA. Grape Leucoanthocyanidin Protects Liver Tissue in Albino Rabbits with Nonalcoholic Hepatic Steatosis. Cells Tissues Organs 2018;205:129-36. [PMID: 29913455 DOI: 10.1159/000489166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
33 Barbosa RJ, Ratti da Silva G, Cola IM, Kuchler JC, Coelho N, Barboza LN, Menetrier JV, de Souza R, Zonta FN, Froehlich DL, Jacomassi E, Soares AA, Velasques LG, Veiga AA, Souza LM, Lovato ECW, Ribeiro-Paes JT, Gasparotto Junior A, Acco A, Lívero FADR. Promising therapeutic use of Baccharis trimera (less.) DC. as a natural hepatoprotective agent against hepatic lesions that are caused by multiple risk factors. J Ethnopharmacol 2020;254:112729. [PMID: 32145332 DOI: 10.1016/j.jep.2020.112729] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Aydos LR, do Amaral LA, Jacobowski AC, de Souza RS, Parisotto EB, de Menezes MB, Junior FFB, Fernandes ES, Silva IS, Portugal LC, Oliveira CG, Masuko GTS, Cavalheiro LF, Nazário CED, Dos Santos EF, Macedo MLR. Buriti pulp oil did not improve high-fat diet-induced metabolic disorders in c57bl/6 mice. J Anim Physiol Anim Nutr (Berl) 2021;105:364-75. [PMID: 33226712 DOI: 10.1111/jpn.13473] [Reference Citation Analysis]
35 Elvira-Torales LI, García-Alonso J, Periago-Castón MJ. Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review. Antioxidants (Basel) 2019;8:E229. [PMID: 31330977 DOI: 10.3390/antiox8070229] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
36 Ferramosca A, Lorenzetti S, Di Giacomo M, Lunetti P, Murrieri F, Capobianco L, Dolce V, Coppola L, Zara V. Modulation of Human Sperm Mitochondrial Respiration Efficiency by Plant Polyphenols. Antioxidants (Basel) 2021;10:217. [PMID: 33540578 DOI: 10.3390/antiox10020217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Pani S, Sahoo A, Patra A, Debata PR. Phytocompounds curcumin, quercetin, indole-3-carbinol, and resveratrol modulate lactate-pyruvate level along with cytotoxic activity in HeLa cervical cancer cells. Biotechnol Appl Biochem 2020. [PMID: 33099806 DOI: 10.1002/bab.2061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Róvero Costa M, Leite Garcia J, Cristina Vágula de Almeida Silva C, Junio Togneri Ferron A, Valentini Francisqueti-Ferron F, Kurokawa Hasimoto F, Schmitt Gregolin C, Henrique Salomé de Campos D, Roberto de Andrade C, Dos Anjos Ferreira AL, Renata Corrêa C, Moreto F. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats. Antioxidants (Basel) 2019;8:E276. [PMID: 31387231 DOI: 10.3390/antiox8080276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
39 Jonscher KR, Bruce KD. Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions. Adv Exp Med Biol 2019;1134:33-58. [PMID: 30919331 DOI: 10.1007/978-3-030-12668-1_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Kim SK, Lee S, Lee MK, Lee S. A systems pharmacology approach to investigate the mechanism of Oryeong-san formula for the treatment of hypertension. J Ethnopharmacol 2019;244:112129. [PMID: 31376514 DOI: 10.1016/j.jep.2019.112129] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
41 Morio B, Panthu B, Bassot A, Rieusset J. Role of mitochondria in liver metabolic health and diseases. Cell Calcium 2021;94:102336. [PMID: 33387847 DOI: 10.1016/j.ceca.2020.102336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Grattagliano I, Di Ciaula A, Baj J, Molina-Molina E, Shanmugam H, Garruti G, Wang DQ, Portincasa P. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD). Methods Mol Biol 2021;2310:201-46. [PMID: 34096005 DOI: 10.1007/978-1-0716-1433-4_12] [Reference Citation Analysis]
43 Yang XX, Wang X, Shi TT, Dong JC, Li FJ, Zeng LX, Yang M, Gu W, Li JP, Yu J. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum. Biomed Pharmacother. 2019;117:109083. [PMID: 31387169 DOI: 10.1016/j.biopha.2019.109083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
44 Oyarzún JE, Andia ME, Uribe S, Núñez Pizarro P, Núñez G, Montenegro G, Bridi R. Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic Cells. Molecules 2020;26:E6. [PMID: 33374984 DOI: 10.3390/molecules26010006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Grattagliano I, Montezinho LP, Oliveira PJ, Frühbeck G, Gómez-Ambrosi J, Montecucco F, Carbone F, Wieckowski MR, Wang DQ, Portincasa P. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. Biochem Pharmacol 2019;160:34-45. [PMID: 30508523 DOI: 10.1016/j.bcp.2018.11.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
46 Yang B, Sun J, Liang S, Wu P, Lv R, He Y, Li D, Sun W, Song X. Prediction of Srebp-1 as a Key Target of Qing Gan San Against MAFLD in Rats via RNA-Sequencing Profile Analysis. Front Pharmacol 2021;12:680081. [PMID: 34290609 DOI: 10.3389/fphar.2021.680081] [Reference Citation Analysis]
47 Ajith TA. Role of mitochondria and mitochondria-targeted agents in non-alcoholic fatty liver disease. Clin Exp Pharmacol Physiol. 2018;45:413-421. [PMID: 29112771 DOI: 10.1111/1440-1681.12886] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
48 Khalil M, Khalifeh H, Baldini F, Salis A, Damonte G, Daher A, Voci A, Vergani L. Antisteatotic and antioxidant activities of Thymbra spicata L. extracts in hepatic and endothelial cells as in vitro models of non-alcoholic fatty liver disease. Journal of Ethnopharmacology 2019;239:111919. [DOI: 10.1016/j.jep.2019.111919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]